Press release
Heparin Market: North America could be leading the market with a US$6.0 bn secured under its belt
The global heparin market is prognosticated by Transparency Market Research (TMR) to hold a highly consolidated nature where a number of large global companies and a handful of local players could be operating. The report has studied crucial players such as Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc., B. Braun Melsungen AG, and Syntex S.A.View Research Report Preview at https://www.transparencymarketresearch.com/heparin-market.html
TMR has envisaged the global heparin market to earn an around US$16.3 bn by the end of 2025 while rising at a CAGR of 6.2% during the forecast time frame 2017-2025. In 2017, the market earned an approximately US$10.1 bn. With respect to segmentation by product, low molecular weight heparin (LMWH) could account for a colossal share in the market by the completion of the forecast period. Regionally, North America has been anticipated to secure a lion’s share while expanding at a 5.6% CAGR.
Read Report Overview: http://globenewswire.com/news-release/2017/12/18/1263139/0/en/Global-Heparin-Market-Value-to-reach-US-16-3-billion-by-the-End-of-2025-Transparency-Market-Research.html
Anticoagulation Properties Expansively Explored in Treatment of Thromboembolic Disorders
The world heparin market has been prognosticated to rise aggressively in the foreseeable future due to the rising occurrences of thromboembolic disorders. Since years, heparin has been broadly used as an anticoagulant in the treatment and prevention of such disorders. The possible comeback of bovine heparin in the U.S. market by 2022 after reintroduction proposals made by the United States Pharmacopeia (USP) and U.S. Food and Drug Administration (FDA) could raise the hopes of industry players. On the other hand, this could help to address concerns about heparin shortage and adulteration.
After warfarin, heparin is mostly recommended in the treatment for coagulation disorders and during surgical procedures. It is also advisory to administer heparin to patients suffering from transient ischemic attack or stroke and unstable angina. Heparin therapy could be used for such patients owing to the quick onset of anticoagulation activity. Increasing cases of deep vein thrombosis (DVT) and pulmonary embolism (PE) have been prophesied to set the tone for a valuable growth in the market. In the U.K., one in every 1,000 individuals is affected by DVT each year, as per the National Health Service (NHS) data.
Request Heparin Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=803
Adverse Effects and Possibility of Contamination Promote Disappointed Growth
Primitive forms of heparin such as unfractionated heparin (UFH) could have limited bioavailability and variable anticoagulant effect foretold to affect the acceptance and sales of heparin-based products. Adverse effects such as heparin-induced thrombocytopenia (HIT) and hemorrhage could also discourage the adoption of UFH. However, as compared to LMWH and ultra-low molecular weight heparin (ULMWH), the reversal of heparin overdose associated with UFH could be easily achieved using protamine sulfate.
Poor yield and the risk of contamination associated with ULMWH have been foreseen to negatively impact its growth in the international heparin market. Moreover, the increased cost of ULMWH owing to chemical-based techniques used for synthesizing and processing could dilute its demand. However, this restraint of the ULMWH market has been expected to be countered with the development of two new methods researched at the University of North Carolina via a series of the bio-enzymatic process. The market could be propelled further with possible price containment because of the emergence of the generic editions of Arixtra.
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heparin Market: North America could be leading the market with a US$6.0 bn secured under its belt here
News-ID: 993513 • Views: …
More Releases from TMR - Research Report

Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview
The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of…

Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local…

External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices…

Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is…
More Releases for LMWH
Heparin Market Growth Driven by Cardiovascular Disease Burden, Preference for LM …
Heparin market reached US$ 8.75 Billion in 2024 and is expected to reach US$ 12.26 Billion by 2033, growing at a CAGR of 3.8% during the forecast period 2025-2033..
Heparin Market is positioned for robust growth, with advancements in [relevant tech or sector] and shifting market dynamics reshaping the competitive landscape. DataM Intelligence's new report provides data-driven insights, SWOT analysis, and marketing-ready intelligence for businesses seeking to improve market penetration and…
Bridging Clotting Solutions: Low Molecular Weight Heparin Market (2023-2033)
The global Low Molecular Weight Heparin Market was valued at 3.8 billion in 2022 and it is anticipated to grow up to USD 8.5 billion by 2032, at a CAGR of 8.4% during the forecast period.
Market Outlook:
The Low Molecular Weight Heparin (LMWH) Market is set for a transformative period as we delve into the years 2023 to 2033. A pivotal player in anticoagulation therapy, the market is positioned for substantial…
Low Molecular Weight Heparin Market worth USD 8.5 billion by 2032 - Changzhou Qi …
The global Low Molecular Weight Heparin Market was valued at 3.8 billion in 2022 and it is anticipated to grow up to USD 8.5 billion by 2032, at a CAGR of 8.4% during the forecast period.
To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10497
Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and…
Low Molecular Weight Heparin Market worth USD 8.5 billion by 2032 - Changzhou Qi …
The global Low Molecular Weight Heparin Market was valued at 3.8 billion in 2022 and it is anticipated to grow up to USD 8.5 billion by 2032, at a CAGR of 8.4% during the forecast period.
To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10497
Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and…
Heparin Market Report 2023 | Increasing the Advantages of Low Molecular Weight H …
According to Precision Business Insights (PBI), the latest report the global heparin market size was valued at USD 7,923.7 million in 2022 and is projected to grow at a 2.8% CAGR during the forecast period 2023 to 2029. The efficacy of these drugs as an anticoagulant is one of the key factors expected to drive global market growth. Furthermore, undeniable factors such as technological advancement and introducing of new products…
Low Molecular Weight Heparin Market at a CAGR of 8.4% during the forecast 202 …
The global Low Molecular Weight Heparin Market was valued at 3.8 billion in 2022 and it is anticipated to grow up to USD 8.5 billion by 2032, at a CAGR of 8.4% during the forecast period.
Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and myocardial infarction, and prevent blood clots. Low molecular weight heparin offers…